cbdMD, Inc. (YCBD) stock
YCBDNYSEPerfumes, Cosmetics & Other Toilet PreparationsFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 10/3081% below fair value
$0.36+0.00 (+0.28%)
Close on Nov 17, 2026Market cap $4.08MP/E –Yield –
cbdMD operating margin
Operating margin is operating income as a percentage of revenue.
cbdMD's operating margin for the twelve months ending Jun 30, 2026 was -13.9%. For fiscal 2025 it was -11.3%, against -17.0% the year before. The highest annual figure on record is -11.3% in fiscal 2025.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | -11.3% | +5.7 |
| FY2024 | Sep 30, 2024 | -17.0% | +76.1 |
| FY2023 | Sep 30, 2023 | -93.1% | +128.0 |
| FY2022 | Sep 30, 2022 | -221.1% | −177.0 |
| FY2021 | Sep 30, 2021 | -44.1% | −2.1 |
| FY2020 | Sep 30, 2020 | -42.0% | +20.6 |
| FY2019 | Sep 30, 2019 | -62.6% | +328.9 |
| FY2018 | Sep 30, 2018 | -391.4% | −361.0 |
| FY2017 | Sep 30, 2017 | -30.4% | +161.0 |
| FY2016 | Sep 30, 2016 | -191.4% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026CQ2 2026 | Jun 30, 2026 | -20.4% | −0.7 |
| Q2 FY2026CQ1 2026 | Mar 31, 2026 | -14.2% | −4.0 |
| Q1 FY2026CQ4 2025 | Dec 31, 2025 | -5.7% | −4.0 |
| Q4 FY2025CQ3 2025 | Sep 30, 2025 | -14.5% | −7.6 |
| Q3 FY2025CQ2 2025 | Jun 30, 2025 | -19.6% | −12.3 |
| Q2 FY2025CQ1 2025 | Mar 31, 2025 | -10.2% | +25.2 |
| Q1 FY2025CQ4 2024 | Dec 31, 2024 | -1.7% | +18.1 |
| Q4 FY2024CQ3 2024 | Sep 30, 2024 | -6.9% | +259.5 |
| Q3 FY2024CQ2 2024 | Jun 30, 2024 | -7.4% | +22.4 |
| Q2 FY2024CQ1 2024 | Mar 31, 2024 | -35.4% | −13.0 |
| Q1 FY2024CQ4 2023 | Dec 31, 2023 | -19.8% | +46.7 |
| Q4 FY2023CQ3 2023 | Sep 30, 2023 | -266.5% | −75.8 |
| Q3 FY2023CQ2 2023 | Jun 30, 2023 | -29.8% | +355.7 |
| Q2 FY2023CQ1 2023 | Mar 31, 2023 | -22.4% | +49.2 |
| Q1 FY2023CQ4 2022 | Dec 31, 2022 | -66.5% | −3.3 |
| Q4 FY2022CQ3 2022 | Sep 30, 2022 | -190.6% | −155.3 |
| Q3 FY2022CQ2 2022 | Jun 30, 2022 | -385.5% | −371.2 |
| Q4 FY2021CQ3 2021 | Sep 30, 2021 | -71.6% | −32.9 |
| Q3 FY2021CQ2 2021 | Jun 30, 2021 | -63.2% | −50.6 |
| Q2 FY2021CQ1 2021 | Mar 31, 2021 | -35.3% | +24.3 |
| Q1 FY2021CQ4 2020 | Dec 31, 2020 | -14.3% | +46.0 |
| Q4 FY2020CQ3 2020 | Sep 30, 2020 | -38.7% | +15.9 |
| Q3 FY2020CQ2 2020 | Jun 30, 2020 | -12.6% | +68.2 |
| Q2 FY2020CQ1 2020 | Mar 31, 2020 | -59.6% | −23.6 |
| Q1 FY2020CQ4 2019 | Dec 31, 2019 | -60.2% | +174.2 |
| Q4 FY2019CQ3 2019 | Sep 30, 2019 | -54.6% | +134.4 |
| Q3 FY2019CQ2 2019 | Jun 30, 2019 | -80.8% | −100.4 |
| Q2 FY2019CQ1 2019 | Mar 31, 2019 | -36.0% | −88.6 |
| Q1 FY2019CQ4 2018 | Dec 31, 2018 | -234.4% | −45.7 |
| Q4 FY2018CQ3 2018 | Sep 30, 2018 | -189.0% | −163.5 |
| Q3 FY2018CQ2 2018 | Jun 30, 2018 | 19.6% | +29.6 |
| Q2 FY2018CQ1 2018 | Mar 31, 2018 | 52.6% | +67.6 |
| Q1 FY2018CQ4 2017 | Dec 31, 2017 | -188.7% | +159.3 |
| Q4 FY2017CQ3 2017 | Sep 30, 2017 | -25.5% | – |
| Q3 FY2017CQ2 2017 | Jun 30, 2017 | -10.0% | – |
| Q2 FY2017CQ1 2017 | Mar 31, 2017 | -15.0% | – |
| Q1 FY2017CQ4 2016 | Dec 31, 2016 | -348.0% | – |
See a number that looks wrong?